When to Recheck Testosterone After Discontinuation
After discontinuing testosterone therapy, wait until hematocrit decreases to a safe level (below 54%) before rechecking testosterone levels and restarting at a reduced dose. The guidelines do not specify an exact time interval, as the priority is ensuring hematocrit normalization rather than adhering to a fixed timeline 1.
Clinical Approach
Immediate Management After Discontinuation
When testosterone therapy is stopped due to elevated hematocrit (>54%), the focus shifts to:
- Monitor hematocrit decline until it reaches a safe level
- Evaluate for underlying causes of polycythemia, specifically hypoxia and sleep apnea 1
- Only after hematocrit normalizes should you consider measuring testosterone levels
Timing Considerations Based on Formulation
The pharmacokinetics of testosterone gel (50 mg daily) are relevant here:
- Testosterone gel has a 24-hour absorption period with approximately 10% of applied testosterone absorbed systemically 2
- Steady-state is achieved by day 30 of treatment 2
- Testosterone half-life ranges from 10-100 minutes for the active hormone itself 2
However, the practical washout period is longer because:
- Testosterone stored in skin acts as a reservoir 2
- Hematocrit elevation persists beyond immediate testosterone clearance
- The guidelines prioritize hematocrit normalization over arbitrary time intervals
Practical Timeline
While not explicitly stated in guidelines, clinical reasoning suggests:
- Stop testosterone immediately when hematocrit >54%
- Recheck hematocrit in 2-4 weeks (based on typical red blood cell lifespan and clinical practice)
- Once hematocrit is <54% (ideally <50%), then measure testosterone level
- Restart at reduced dose only after confirming both hematocrit normalization and assessing current testosterone status
Monitoring After Restart
When reinitiating therapy at a lower dose 1:
- Measure testosterone 3-6 months after restart to ensure mid-normal range levels
- Recheck hematocrit at 3-6 months, then annually
- For transdermal gels specifically: assess testosterone any time after at least 1 week on the new dose 1
Important Caveats
The guidelines deliberately avoid specifying exact washout times because individual variation in hematocrit recovery is substantial. Factors affecting recovery include:
- Baseline hematocrit before treatment
- Duration of elevated hematocrit
- Presence of sleep apnea or chronic hypoxia
- Individual erythropoietic response
Do not restart testosterone until you have:
- Documented hematocrit <54% (preferably <50%)
- Ruled out or addressed sleep apnea and hypoxia
- Confirmed the patient understands the need for dose reduction
The dose reduction should be meaningful—not just a token adjustment—to prevent recurrent polycythemia 1.